The novel treatment of this peptide represents a significant advance in the management of diabetes mellitus type 2. Unlike existing drugs, tirzepatide targets multiple pathways – GLP-1 and GIP – resulting in https://tirzepatidepeptide119745.ampedpages.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-69055275